General Info

Epigenomics is a molecular diagnostics company that focuses on the development and commercialization of in vitro diagnostic tests for cancer. The company provides colorectal, prostate and lung cancer screening services. It offers proprietary DNA methylation amplification technologies for the development of highly quantitative and sensitive DNA methylation assays for clinical sample collections. Epigenomics service areas include the United States, Europe and Japan. It works in partnership with Abbott Molecular and Quest Diagnostics. Headquartered in Berlin, it maintains a location in Seattle.